HENDERSON, Nev. – March 25, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial results for the fourth quarter and full-year 2024.
“2024 marked another year of outstanding growth and strategic advancement for Paysign, demonstrated by our strong revenue increase of 23.5%, an impressive 400 basis point improvement in gross margins and an equally impressive 230 basis point improvement in adjusted EBITDA margins. We are particularly pleased with the exceptional performance of our patient affordability business, which grew revenues by 214.5% over the prior year and concluded 2024 with 76 active programs, reflecting a net addition of 33 programs” said Mark Newcomer, President & CEO of Paysign. “Our patient affordability represented 21.7% of our revenue in 2024 and we expect that to increase to over 37.0% of revenue in 2025 as our pipeline remains robust. Looking ahead, we are thrilled to embark on a new chapter for Paysign, driven by our strategic acquisition of the assets of Gamma Innovation, LLC, announced earlier today. The integration of Gamma’s cutting-edge software solutions greatly strengthens our capabilities in plasma donor and pharmaceutical patient engagement, adherence, resource management and market intelligence. This positions us exceptionally well to expand our presence in the life sciences market and beyond. As always, we remain deeply committed to delivering long-term value to our shareholders.”
Click here for the full earnings release.